Cynthia Collins
CIK: 0001405692
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (14 total)
- Jun 17, 2026MXCT
MAXCYTE, INC.
Award(A)Direct30.4K shares- - Jun 17, 2026CDXS
CODEXIS, INC.
Award(A)DirectStock Option (Right to Buy)
66.4K shares- - May 14, 2026CERT
Certara, Inc.
Exercise(M)Direct15.8K shares- - Jun 18, 2025MXCT
MAXCYTE, INC.
Award(A)Direct29.2K shares- - Jun 10, 2025CDXS
CODEXIS, INC.
Award(A)Direct41K shares- - May 21, 2025CERT
Certara, Inc.
Exercise(M)Direct11.9K shares- - May 21, 2025CERT
Certara, Inc.
Award(A)DirectRestricted Stock Units
15.8K shares- - Mar 28, 2025CDXS
CODEXIS, INC.
Award(A)Direct71.2K shares- - Jan 8, 2025PSTX
Poseida Therapeutics, Inc.
Tender Offer(U)Direct59K shares- - Jan 8, 2025PSTX
Poseida Therapeutics, Inc.
Disposition(D)DirectStock Option (Right to Buy)
87.4K shares- - Jan 8, 2025PSTX
Poseida Therapeutics, Inc.
Disposition(D)DirectStock Option (Right to Buy)
28.5K shares- - Jan 8, 2025PSTX
Poseida Therapeutics, Inc.
Disposition(D)DirectStock Option (Right to Buy)
27.4K shares- - Jan 8, 2025PSTX
Poseida Therapeutics, Inc.
Disposition(D)DirectStock Option (Right to Buy)
27.4K shares- - Oct 14, 2024MXCT
MAXCYTE, INC.
Award(A)Direct51.7K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 17, 2026 |  MXCT MAXCYTE, INC. | Award(A) | 30,421 | - | $0 | Direct |
| Jun 17, 2026 |  CDXS CODEXIS, INC. | Award(A) Stock Option (Right to Buy) | 66,350 | - | - | Direct |
| May 14, 2026 |  CERT Certara, Inc. | Exercise(M) | 15,757 | - | $0 | Direct |
| Jun 18, 2025 | MXCT MAXCYTE, INC. | Award(A) | 29,210 | - | - | Direct |
| Jun 10, 2025 | CDXS CODEXIS, INC. | Award(A) | 40,983 | - | - | Direct |
| May 21, 2025 | CERT Certara, Inc. | Exercise(M) | 11,928 | - | - | Direct |
| May 21, 2025 | CERT Certara, Inc. | Award(A) Restricted Stock Units | 15,757 | - | - | Direct |
| Mar 28, 2025 | CDXS CODEXIS, INC. | Award(A) | 71,174 | - | - | Direct |
| Jan 8, 2025 |  PSTX Poseida Therapeutics, Inc. | Tender Offer(U) | 58,950 | - | $0 | Direct |
| Jan 8, 2025 | PSTX Poseida Therapeutics, Inc. | Disposition(D) Stock Option (Right to Buy) | 87,440 | - | - | Direct |
| Jan 8, 2025 | PSTX Poseida Therapeutics, Inc. | Disposition(D) Stock Option (Right to Buy) | 28,500 | - | - | Direct |
| Jan 8, 2025 | PSTX Poseida Therapeutics, Inc. | Disposition(D) Stock Option (Right to Buy) | 27,350 | - | - | Direct |
| Jan 8, 2025 | PSTX Poseida Therapeutics, Inc. | Disposition(D) Stock Option (Right to Buy) | 27,350 | - | - | Direct |
| Oct 14, 2024 | MXCT MAXCYTE, INC. | Award(A) | 51,679 | - | $0 | Direct |
1-14 of 14 transactions
About Collins Cynthia
Collins Cynthia (SEC CIK 0001405692) files insider reports with the SEC as Director of MAXCYTE, INC. (MXCT), Director of CODEXIS, INC. (CDXS) and Director of Certara, Inc. (CERT). Signal8 also holds filings tied to 1 other company.
Signal8 holds 11 ownership filings by Collins Cynthia (2 Form 3, 9 Form 4), filed between Oct 16, 2024 and Jun 22, 2026. Those filings report 14 transactions, from Oct 14, 2024 to Jun 17, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Collins Cynthia's filings is in REDWOOD CITY, CA.
Recent filings by Collins Cynthia
- Jun 17, 2026: Grant or award of MXCT shares (Form 4, code A).
- Jun 17, 2026: Grant or award of CDXS derivative securities (Form 4, code A).
- May 14, 2026: Option exercise of CERT shares (Form 4, code M).
- Jun 18, 2025: Grant or award of MXCT shares (Form 4, code A).
- Jun 10, 2025: Grant or award of CDXS shares (Form 4, code A).
Other insiders filing for MAXCYTE, INC. (MXCT)
- Johnston John Joseph, Director
- Hemrajani Rekha, Director
- Erck Stanley C, Director
- DOUGLAS RICHARD, Director
- Brooke William W, Director
- BALTHROP PATRICK J, Director